Table 2.

Human leukocyte antigen (HLA) information

	HLA‐A		HLA‐B		HLA‐C
TL‐Su	*11:01	*24:02	*15:01	*40:02	*03:04	*04:01
TCL‐Kan	*02:06	*02:07	*46:01	*56:01	*01:02	*07:02
K562
HUT102	*30:02	*66:02
ATN‐1	*11:01	*24:02	*54:01	*67:01	*01:02	*07:02
MT‐1	*11:01	*26:01	*39:01	*40:02	*03:04	*07:02
MT‐2	*24:02	*24:02	*40:02	*51:01	*03:03	*14:02
MT‐4	*11:01	*31:01	*39:02	*67:01	*07:02	*07:02
TL‐Om1	*02:01	*02:01	*52:01	*52:01	*12:02	*12:02
Patient 1	*02:01	*02:01	*15:01	*40:02	*03:04	*07:02
Patient 3	*02:01	*31:01
Patient 4	*24:02	*26:01
Patient 5	*02:06	*24:02
Patient 6	*02:06	*31:01
Patient 7	*02:07	*24:02	*46:01	*52:01	*01:02	*12:02
Patient 8	*02:01	*02:06	*35:01	*55:02	*01:02	*03:03
Patient 9	*02:01	*31:01
Patient 10	*11:01	*24:02
Patient 11	*11:01	*24:02
Patient 12	*02:06	*24:02
Patient 13	*02:03	*31:01
Patient 14	*24:02	*31:01	*07:02	*40:01	*03:04	*07:02